Group One Trading
NVCR icon

Group One Trading’s NovoCure NVCR Stock Holding History

Group One Trading’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,597
Closed -$282K – 8400
2025
Q4 		$292K Buy
22,597
+10,249
+83% +$132K ﹤0.01% 4040
2025
Q3 		$160K Buy
+12,348
New +$165K ﹤0.01% 4913
2024
Q4 		– Sell
-55,616
Closed -$1.18M – 7744
2024
Q3 		$869K Buy
55,616
+43,140
+346% +$782K ﹤0.01% 2422
2024
Q2 		$214K Sell
12,476
-53,719
-81% -$945K ﹤0.01% 3331
2024
Q1 		$1.03M Sell
66,195
-129,245
-66% -$1.9M ﹤0.01% 2055
2023
Q4 		$2.92M Buy
+195,440
New +$2.62M 0.01% 1549
2023
Q3 		– Sell
-45,184
Closed -$1.3M – 8085
2023
Q2 		$1.88M Buy
45,184
+21,595
+92% +$1.34M 0.01% 1767
2023
Q1 		$1.42M Buy
+23,589
New +$1.89M 0.01% 1829
2022
Q1 		– Sell
-49,390
Closed -$3.64M – 8472
2021
Q4 		$3.71M Buy
49,390
+32,827
+198% +$3.3M ﹤0.01% 1972
2021
Q3 		$1.92M Buy
+16,563
New +$2.5M ﹤0.01% 2694
2020
Q3 		– Sell
-15,714
Closed -$1.26M – 6403
2020
Q2 		$932K Buy
+15,714
New +$1.03M ﹤0.01% 2086
2020
Q1 		– Sell
-2,822
Closed -$223K – 5596
2019
Q4 		$238K Buy
2,822
+1,864
+195% +$150K ﹤0.01% 3051
2019
Q3 		$72K Buy
+958
New +$76.6K ﹤0.01% 3780
2018
Q4 		– Sell
-15,019
Closed -$549K – 5236
2018
Q3 		$787K Buy
15,019
+5,895
+65% +$235K 0.01% 1895
2018
Q2 		$286K Buy
9,124
+8,503
+1,369% +$237K ﹤0.01% 2758
2018
Q1 		$14K Sell
621
-8,525
-93% -$183K ﹤0.01% 4212
2017
Q4 		$185K Buy
+9,146
New +$176K ﹤0.01% 2971
2016
Q1 		– Sell
-1,508
Closed -$21.6K – 4818
2015
Q4 		$34K Buy
+1,508
New +$36K ﹤0.01% 3636

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Group One Trading's NVCR Position: Q1 2026 in Review

Group One Trading sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 22,597 shares — an estimated $282K sold.

Group One Trading first reported a position in NVCR in Q4 2015 and held it in 18 quarters. The position peaked at $3.71M in Q4 2021. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Group One Trading reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 22,597 NovoCure shares in Q1 2026, an estimated $282K.
  • Group One Trading first reported a position in NovoCure in Q4 2015 and held it in 18 quarters.
  • Group One Trading's NovoCure position peaked at $3.71M in Q4 2021.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.